Zobrazeno 1 - 10
of 540
pro vyhledávání: '"S. Jarius"'
Autor:
S. Jarius, B. Wildemann
Publikováno v:
Journal of Neuroinflammation, Vol 16, Iss 1, Pp 1-30 (2019)
Abstract Neuromyelitis optica (NMO) was long considered a clinical variant of multiple sclerosis (MS). However, the discovery of a novel and pathogenic anti-astrocytic serum autoantibody targeting aquaporin-4 (termed NMO-IgG or AQP4-Ab), the most abu
Externí odkaz:
https://doaj.org/article/bfe7e5f79bbd4e05a6248effb79a13d5
Autor:
M. N. Olesen, K. Soelberg, B. Debrabant, A. C. Nilsson, S. T. Lillevang, J. Grauslund, I. Brandslund, J. S. Madsen, F. Paul, T. J. Smith, S. Jarius, N. Asgari
Publikováno v:
Journal of Neuroinflammation, Vol 16, Iss 1, Pp 1-12 (2019)
Abstract Background Long-term outcome in multiple sclerosis (MS) depends on early treatment. In patients with acute optic neuritis (ON), an early inflammatory event, we investigated markers in cerebrospinal fluid (CSF), which may predict a diagnosis
Externí odkaz:
https://doaj.org/article/e2be5c0a4fdc42e78e1de38391cbeb9d
Publikováno v:
Journal of Neuroinflammation, Vol 16, Iss 1, Pp 1-14 (2019)
Abstract Background Myelinoclastic diffuse sclerosis (MDS; also termed Schilder’s disease) is a rare inflammatory demyelinating disorder of the central nervous system characterised by demyelination of vast areas of the white matter. It is unclear w
Externí odkaz:
https://doaj.org/article/4256c4e3460d4ce7951bc671579092ee
Autor:
S. Jarius, F. Paul, O. Aktas, N. Asgari, R. C. Dale, J. de Seze, D. Franciotta, K. Fujihara, A. Jacob, H. J. Kim, I. Kleiter, T. Kümpfel, M. Levy, J. Palace, K. Ruprecht, A. Saiz, C. Trebst, B. G. Weinshenker, B. Wildemann
Publikováno v:
Journal of Neuroinflammation, Vol 15, Iss 1, Pp 1-10 (2018)
Abstract Over the past few years, new-generation cell-based assays have demonstrated a robust association of autoantibodies to full-length human myelin oligodendrocyte glycoprotein (MOG-IgG) with (mostly recurrent) optic neuritis, myelitis and brains
Externí odkaz:
https://doaj.org/article/1dfbca0b7d634be58a08cea01226cdfb
Autor:
S. Jarius, K. Ruprecht, J. P. Stellmann, A. Huss, I. Ayzenberg, A. Willing, C. Trebst, M. Pawlitzki, A. Abdelhak, T. Grüter, F. Leypoldt, J. Haas, I. Kleiter, H. Tumani, K. Fechner, M. Reindl, F. Paul, B. Wildemann
Publikováno v:
Journal of Neuroinflammation, Vol 15, Iss 1, Pp 1-5 (2018)
Abstract Background Antibodies to human full-length myelin oligodendrocyte glycoprotein (MOG-IgG) as detected by new-generation cell-based assays have recently been described in patients presenting with acute demyelinating disease of the central nerv
Externí odkaz:
https://doaj.org/article/35a6f708ff424e5f82891ba67eebc0a0
Publikováno v:
Journal of Neuroinflammation, Vol 15, Iss 1, Pp 1-8 (2018)
Abstract Background Baló’s concentric sclerosis (BCS) is a rare inflammatory demyelinating disorder of the central nervous system characterised by concentric layers of demyelination. It is unclear whether BCS is a variant of multiple sclerosis (MS
Externí odkaz:
https://doaj.org/article/2f1f30326ac54b13926b860e3956ac01
Publikováno v:
Journal of Neuroinflammation, Vol 14, Iss 1, Pp 1-14 (2017)
Abstract Background The diagnosis of multiple sclerosis (MS) is currently based solely on clinical and magnetic resonance imaging features. However, histopathological studies have revealed four different patterns of lesion pathology in patients diagn
Externí odkaz:
https://doaj.org/article/f72965176ea94c06b2d7164ae0e12ceb
Autor:
S. Hahn, G. Trendelenburg, M. Scharf, Y. Denno, S. Brakopp, B. Teegen, C. Probst, K. P. Wandinger, M. Buttmann, A. Haarmann, F. Szabados, M. vom Dahl, T. Kümpfel, P. Eichhorn, H. Gold, F. Paul, S. Jarius, N. Melzer, W. Stöcker, L. Komorowski
Publikováno v:
Journal of Neuroinflammation, Vol 14, Iss 1, Pp 1-10 (2017)
Abstract Background Autoantibodies, in particular those against aquaporin-4 and myelin-oligodendrocyte glycoprotein (MOG), aid as biomarkers in the differential diagnosis of demyelination. Here, we report on discovery of autoantibodies against flotil
Externí odkaz:
https://doaj.org/article/b92f82dff9f84a5582a53fb01ca4b7e4
Publikováno v:
Journal of Neurology. 269:5198-5212
Background In around 20% of cases, myelin oligodendrocyte glycoprotein (MOG) immunoglobulin (IgG)-associated encephalomyelitis (MOG-EM; also termed MOG antibody-associated disease, MOGAD) first occurs in a postinfectious or postvaccinal setting. Obje
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.